Cilostazol improves long-term outcomes after coronary stent implantation - 21/08/11
Doi : 10.1016/j.ahj.2005.06.021
Yaling Han, MD a, ⁎ 
, Shouli Wang, MD a, Yi Li, MD a, Quanmin Jing, MD a, Yingyan Ma, MD a, Jie Deng, MD a, Guitang Yang, MD a, Haibo Yu, MD a, Junbo Ge, MD b
, Shouli Wang, MD a, Yi Li, MD a, Quanmin Jing, MD a, Yingyan Ma, MD a, Jie Deng, MD a, Guitang Yang, MD a, Haibo Yu, MD a, Junbo Ge, MD b a Department of Cardiology, Northern Hospital, Shenyang, China
b Department of Cardiology, Zhongshan Hospital, Shanghai, China
⁎Reprint requests: Yaling Han, MD, Department of Cardiology, Northern Hospital, 83 Wenhua Road, Shenyang, 110016, PR China.
Vol 150 - N° 3
P. 568.e1-568.e5 - septembre 2005 Retour au numéro
Article précédent
- Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction
- Leonardo De Luca, Paola Proietti, Annalisa Celotto, Chiara Bucciarelli-Ducci, Giulia Benedetti, Angelo Di Roma, Gennaro Sardella, Igino Genuini, Francesco Fedele
- Temporal variation in inhospital mortality with percutaneous coronary intervention: A report from the National Heart, Lung and Blood Institute Dynamic Registry
- Warren K. Laskey, Faith Selzer, David R. Holmes, Robert L. Wilensky, Howard A. Cohen, David O. Williams, Kevin E. Kip, Katherine M. Detre, on behalf of the NHLBI Dynamic Registry Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?